Review



293t cells  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    OriGene 293t cells
    293t Cells, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pot1/POT1+(NM_015450)+Human+Recombinant+Protein/pm40934081-404-5-10
    Average 93 stars, based on 3 article reviews
    293t cells - by Bioz Stars, 2026-08
    93/100 stars

    Images



    Similar Products

    90
    Thermo Fisher insect cell expression and purification of human pot1
    KEY RESOURCES TABLE
    Insect Cell Expression And Purification Of Human Pot1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pot1/sumostar+hexahistine+pot1+fusion+protein/pmc06599638-534-12-3
    Average 90 stars, based on 1 article reviews
    insect cell expression and purification of human pot1 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    93
    OriGene 293t cells
    KEY RESOURCES TABLE
    293t Cells, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pot1/POT1+(NM_015450)+Human+Recombinant+Protein/pm40934081-404-5-10
    Average 93 stars, based on 1 article reviews
    293t cells - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    90
    GenScript corporation codonoptimized wild-types of human, t. dohrnii, and t. rubra pot1, and their respective modified forms
    KEY RESOURCES TABLE
    Codonoptimized Wild Types Of Human, T. Dohrnii, And T. Rubra Pot1, And Their Respective Modified Forms, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pot1/shelterin+genes++terf1++terf2++terf2ip+rap1++tinf2++acd+tpp1++pot1/pm36037356-192-14-28
    Average 90 stars, based on 1 article reviews
    codonoptimized wild-types of human, t. dohrnii, and t. rubra pot1, and their respective modified forms - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    92
    R&D Systems anti pot1
    KEY RESOURCES TABLE
    Anti Pot1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pot1/Human+POT1+Antibody/pm35660868-156-81-86
    Average 92 stars, based on 1 article reviews
    anti pot1 - by Bioz Stars, 2026-08
    92/100 stars
      Buy from Supplier

    90
    Novus Biologicals a portion of amino acids 450-500 of human pot1
    KEY RESOURCES TABLE
    A Portion Of Amino Acids 450 500 Of Human Pot1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pot1/polyclonal+antibody+nb+500+201/pm33107640-680-66-58
    Average 90 stars, based on 1 article reviews
    a portion of amino acids 450-500 of human pot1 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Addgene inc human pot1 cdna
    KEY RESOURCES TABLE
    Human Pot1 Cdna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pot1/plasmid+plpc+nmyc+pot1/pm31254473-158-0-6
    Average 90 stars, based on 1 article reviews
    human pot1 cdna - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    93
    OriGene pot1
    KEY RESOURCES TABLE
    Pot1, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pot1/POT1+(NM_015450)+Human+Recombinant+Protein/pm27228173-305-21-22
    Average 93 stars, based on 1 article reviews
    pot1 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology human pot1
    ( a ) Primary structure of <t>POT1</t> and TPP1 showing domains and their functional properties. POT1C disease mutations (L343F, P446Q, P475L, R477T, A532P, C591W and Q623H) discussed in this manuscript are also indicated. ( b ) SDS–page gel of the purified POT1C and TPP1(PBD) proteins used in structural and biochemical studies. ( c ) Stereo image of a portion (TPP1 bound to the OB-fold of POT1) of the simulated annealing omit map at 1 sigma contour level. ( d ) X-ray Crystal structure of the human POT1C—TPP1(PBD) complex; The OB-fold and HJR of POT1C are shown in blue and red colours respectively; TPP1(PBD) is shown in green colour. The Zn 2+ ion coordinated by 4 cysteins (C382, C385, C503 and C506—stick) is shown as a cyan sphere. ( e ) Overlay of the POT1C and the Oxytricha nova telomere end binding protein alpha subunit (OnTEBPα—beige colour, PDB ID: 1OTC (ref. )) OB folds. ( f ) Overlay of the POT1C HJR (red colour) with its closest structural homologue Archaeoglobus fulgidus HJR (AfHJR—cyan colour; PDB ID: 2WIW).
    Human Pot1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pot1/POT1+Antibody/pmc05394233-255-77-59
    Average 93 stars, based on 1 article reviews
    human pot1 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology anti human pot1 antibody
    ( a ) Primary structure of <t>POT1</t> and TPP1 showing domains and their functional properties. POT1C disease mutations (L343F, P446Q, P475L, R477T, A532P, C591W and Q623H) discussed in this manuscript are also indicated. ( b ) SDS–page gel of the purified POT1C and TPP1(PBD) proteins used in structural and biochemical studies. ( c ) Stereo image of a portion (TPP1 bound to the OB-fold of POT1) of the simulated annealing omit map at 1 sigma contour level. ( d ) X-ray Crystal structure of the human POT1C—TPP1(PBD) complex; The OB-fold and HJR of POT1C are shown in blue and red colours respectively; TPP1(PBD) is shown in green colour. The Zn 2+ ion coordinated by 4 cysteins (C382, C385, C503 and C506—stick) is shown as a cyan sphere. ( e ) Overlay of the POT1C and the Oxytricha nova telomere end binding protein alpha subunit (OnTEBPα—beige colour, PDB ID: 1OTC (ref. )) OB folds. ( f ) Overlay of the POT1C HJR (red colour) with its closest structural homologue Archaeoglobus fulgidus HJR (AfHJR—cyan colour; PDB ID: 2WIW).
    Anti Human Pot1 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pot1/POT1+Antibody/pmc05394233-255-31-59
    Average 93 stars, based on 1 article reviews
    anti human pot1 antibody - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    90
    Millipore anti-human pot1 antibody
    ( a ) Primary structure of <t>POT1</t> and TPP1 showing domains and their functional properties. POT1C disease mutations (L343F, P446Q, P475L, R477T, A532P, C591W and Q623H) discussed in this manuscript are also indicated. ( b ) SDS–page gel of the purified POT1C and TPP1(PBD) proteins used in structural and biochemical studies. ( c ) Stereo image of a portion (TPP1 bound to the OB-fold of POT1) of the simulated annealing omit map at 1 sigma contour level. ( d ) X-ray Crystal structure of the human POT1C—TPP1(PBD) complex; The OB-fold and HJR of POT1C are shown in blue and red colours respectively; TPP1(PBD) is shown in green colour. The Zn 2+ ion coordinated by 4 cysteins (C382, C385, C503 and C506—stick) is shown as a cyan sphere. ( e ) Overlay of the POT1C and the Oxytricha nova telomere end binding protein alpha subunit (OnTEBPα—beige colour, PDB ID: 1OTC (ref. )) OB folds. ( f ) Overlay of the POT1C HJR (red colour) with its closest structural homologue Archaeoglobus fulgidus HJR (AfHJR—cyan colour; PDB ID: 2WIW).
    Anti Human Pot1 Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pot1/pab+anti+pot1/pmc05394233-256-26-30
    Average 90 stars, based on 1 article reviews
    anti-human pot1 antibody - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    Image Search Results


    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: Two Separation-of-Function Isoforms of Human TPP1 Dictate Telomerase Regulation in Somatic and Germ Cells

    doi: 10.1016/j.celrep.2019.05.073

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: For High Five (Thermo Fisher Scientific) insect cell expression and purification of human POT1 the pFBHTb-Smt3star-hPOT1 was used as described previously ( Kocak et al., 2014 ).

    Techniques: Recombinant, Genome Wide, RNA Sequencing Assay, CRISPR, FLAG-tag, Primer Extension Assay, Software, Mutagenesis, Negative Control, Positive Control

    ( a ) Primary structure of POT1 and TPP1 showing domains and their functional properties. POT1C disease mutations (L343F, P446Q, P475L, R477T, A532P, C591W and Q623H) discussed in this manuscript are also indicated. ( b ) SDS–page gel of the purified POT1C and TPP1(PBD) proteins used in structural and biochemical studies. ( c ) Stereo image of a portion (TPP1 bound to the OB-fold of POT1) of the simulated annealing omit map at 1 sigma contour level. ( d ) X-ray Crystal structure of the human POT1C—TPP1(PBD) complex; The OB-fold and HJR of POT1C are shown in blue and red colours respectively; TPP1(PBD) is shown in green colour. The Zn 2+ ion coordinated by 4 cysteins (C382, C385, C503 and C506—stick) is shown as a cyan sphere. ( e ) Overlay of the POT1C and the Oxytricha nova telomere end binding protein alpha subunit (OnTEBPα—beige colour, PDB ID: 1OTC (ref. )) OB folds. ( f ) Overlay of the POT1C HJR (red colour) with its closest structural homologue Archaeoglobus fulgidus HJR (AfHJR—cyan colour; PDB ID: 2WIW).

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Primary structure of POT1 and TPP1 showing domains and their functional properties. POT1C disease mutations (L343F, P446Q, P475L, R477T, A532P, C591W and Q623H) discussed in this manuscript are also indicated. ( b ) SDS–page gel of the purified POT1C and TPP1(PBD) proteins used in structural and biochemical studies. ( c ) Stereo image of a portion (TPP1 bound to the OB-fold of POT1) of the simulated annealing omit map at 1 sigma contour level. ( d ) X-ray Crystal structure of the human POT1C—TPP1(PBD) complex; The OB-fold and HJR of POT1C are shown in blue and red colours respectively; TPP1(PBD) is shown in green colour. The Zn 2+ ion coordinated by 4 cysteins (C382, C385, C503 and C506—stick) is shown as a cyan sphere. ( e ) Overlay of the POT1C and the Oxytricha nova telomere end binding protein alpha subunit (OnTEBPα—beige colour, PDB ID: 1OTC (ref. )) OB folds. ( f ) Overlay of the POT1C HJR (red colour) with its closest structural homologue Archaeoglobus fulgidus HJR (AfHJR—cyan colour; PDB ID: 2WIW).

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: Functional Assay, SDS Page, Purification, Binding Assay

    ( a ) SDS–PAGE gel of super-telomerase extract (STE) and E. coli purified full-length POT1 (flPOT1) and TPP1(87) proteins used in the direct assay of ( c ). The red arrow indicates where TERT is expected to run (∼130 kDa). The assay in c was carried out in the presence of 150 nM of purified POT1–TPP1 complex. ( b ) Western blot of HEK293T lysates used in the direct assay of panel ( d ). The gel shows the levels of transiently expressed POT1 and TPP1 are much higher than those of TERT, confirming that the direct assays were carried out at saturating levels of POT1 and TPP1. ( c ) Telomerase direct activity assay using 2 μg of STE; 150 nM purified WT or mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1; 150 nM WT TPP1(87); and 20 nM of primer A5 (TTAGGGTTAGCGTTAGGG). ( d ) Telomerase direct activity assay using 5 μg of STE co-transfected with WT or mutant (L343F, P466Q, P475L, R477T, A532P, C591W and Q623H) flPOT1 and WT full-length TPP1 (flTPP1). The STE was supplemented with 20 nM of A5 primer. The number of telomeric repeats added to the primer are indicated on the right of the gels ( c and d , e and f ) Quantification of telomerase processivity of panels ( c ) and ( d ) respectively. The values are the average of four independent experiments; error bars indicate s.d.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) SDS–PAGE gel of super-telomerase extract (STE) and E. coli purified full-length POT1 (flPOT1) and TPP1(87) proteins used in the direct assay of ( c ). The red arrow indicates where TERT is expected to run (∼130 kDa). The assay in c was carried out in the presence of 150 nM of purified POT1–TPP1 complex. ( b ) Western blot of HEK293T lysates used in the direct assay of panel ( d ). The gel shows the levels of transiently expressed POT1 and TPP1 are much higher than those of TERT, confirming that the direct assays were carried out at saturating levels of POT1 and TPP1. ( c ) Telomerase direct activity assay using 2 μg of STE; 150 nM purified WT or mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1; 150 nM WT TPP1(87); and 20 nM of primer A5 (TTAGGGTTAGCGTTAGGG). ( d ) Telomerase direct activity assay using 5 μg of STE co-transfected with WT or mutant (L343F, P466Q, P475L, R477T, A532P, C591W and Q623H) flPOT1 and WT full-length TPP1 (flTPP1). The STE was supplemented with 20 nM of A5 primer. The number of telomeric repeats added to the primer are indicated on the right of the gels ( c and d , e and f ) Quantification of telomerase processivity of panels ( c ) and ( d ) respectively. The values are the average of four independent experiments; error bars indicate s.d.

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: SDS Page, Purification, Western Blot, Activity Assay, Mutagenesis, Transfection

    ( a ) FP assays of POT1C and the POT1C–TPP1(PBD) complex with a single-stranded DNA probe consisting of 3 telomeric repeats (18mer). ( b ) FP assays of the WT and mutant (those that partially disrupt the POT1–TPP1 complex P446Q, C591W and Q623H) flPOT1 with the 18mer DNA probe. ( c ) FP assays of the WT and mutant flPOT1−TPP1(87) complex with the 18mer. ( d ) Bar graph showing the differences in Kd (nM) between the WT and mutant flPOT1 and flPOT1–TPP1(87) complex. The values are the average of three independent measurements and a two-tailed Student's t -test was performed with respect to WT POT1–TPP1(PBD) complex: * P <0.05, ** P <0.01.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) FP assays of POT1C and the POT1C–TPP1(PBD) complex with a single-stranded DNA probe consisting of 3 telomeric repeats (18mer). ( b ) FP assays of the WT and mutant (those that partially disrupt the POT1–TPP1 complex P446Q, C591W and Q623H) flPOT1 with the 18mer DNA probe. ( c ) FP assays of the WT and mutant flPOT1−TPP1(87) complex with the 18mer. ( d ) Bar graph showing the differences in Kd (nM) between the WT and mutant flPOT1 and flPOT1–TPP1(87) complex. The values are the average of three independent measurements and a two-tailed Student's t -test was performed with respect to WT POT1–TPP1(PBD) complex: * P <0.05, ** P <0.01.

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: Mutagenesis, Two Tailed Test

    ( a ) Western blot showing the levels of YFP tagged, WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) full length POT1. We used GFP (αGFP) or POT1 (αPOT1) to detect the levels of YFP-POT1 in each cell line. The band at 71 kDa and below the YFP-aPOT1 is a non specific protein. GAPDH was used as a loading control. ( b ) Maximum projection images of co-localization of YFP-POT1 (green) and Cherry-TRF2 (red) proteins are shown. Merged images include DAPI. Scale bar, 5 μm. The data clearly shows co-localization of WT and mutant flPOT1 proteins to telomeres.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Western blot showing the levels of YFP tagged, WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) full length POT1. We used GFP (αGFP) or POT1 (αPOT1) to detect the levels of YFP-POT1 in each cell line. The band at 71 kDa and below the YFP-aPOT1 is a non specific protein. GAPDH was used as a loading control. ( b ) Maximum projection images of co-localization of YFP-POT1 (green) and Cherry-TRF2 (red) proteins are shown. Merged images include DAPI. Scale bar, 5 μm. The data clearly shows co-localization of WT and mutant flPOT1 proteins to telomeres.

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: Western Blot, Mutagenesis, Control

    ( a ) Quantitative RT-PCR showing knock down of endogenous POT1 mRNA, normalized to GAPDH transcript levels, after lentiviral infection of HEK293T cells with shPOT1 and WT Flag-POT1; selection was carried out with puromycin and blasticidin;±s.d. ( n =3). ( b ) Western blot showing WT and mutant POT1 protein expression levels in HEK293T cells expressing shPOT1 and Flag-POT1. Cells infected with the empty pLU and pLKO.1 lentiviral vectors are used as controls. ( c , d , e ) Southern blot of HEK293T cells expressing shPOT1 and WT or mutant flPOT1. DNA from 5, 50 and 120 populations doublings (PD) is shown. DNA length standards are indicated along the left and right of the gels. The white dashed line indicates the average telomere length of HEK293T cells transfected with the vector alone and no shPOT1 after 5, 50 and 120 PD. The vector (- shPOT1), vector (+shPOT1) and WT POT1 (+shPOT1) controls are indicated with a green and yellow dot respectively. The POT1 mutants (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) are indicated with red dots. ( f ) Quantification of the mean telomere length (kb) from panels ( c , d and e ). The same colour scheme as in panels c , d and e is used. Black bars indicate the range of telomere restriction fragments (TRF).

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Quantitative RT-PCR showing knock down of endogenous POT1 mRNA, normalized to GAPDH transcript levels, after lentiviral infection of HEK293T cells with shPOT1 and WT Flag-POT1; selection was carried out with puromycin and blasticidin;±s.d. ( n =3). ( b ) Western blot showing WT and mutant POT1 protein expression levels in HEK293T cells expressing shPOT1 and Flag-POT1. Cells infected with the empty pLU and pLKO.1 lentiviral vectors are used as controls. ( c , d , e ) Southern blot of HEK293T cells expressing shPOT1 and WT or mutant flPOT1. DNA from 5, 50 and 120 populations doublings (PD) is shown. DNA length standards are indicated along the left and right of the gels. The white dashed line indicates the average telomere length of HEK293T cells transfected with the vector alone and no shPOT1 after 5, 50 and 120 PD. The vector (- shPOT1), vector (+shPOT1) and WT POT1 (+shPOT1) controls are indicated with a green and yellow dot respectively. The POT1 mutants (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) are indicated with red dots. ( f ) Quantification of the mean telomere length (kb) from panels ( c , d and e ). The same colour scheme as in panels c , d and e is used. Black bars indicate the range of telomere restriction fragments (TRF).

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: Quantitative RT-PCR, Knockdown, Infection, Selection, Western Blot, Mutagenesis, Expressing, Southern Blot, Transfection, Plasmid Preparation

    ( a ) Telomeric FISH metaphase spreads of cells expressing WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1 proteins after 50 population doublings (Red, TelC-Tamra; blue, DAPI). Endogenous POT1 levels were reduced with shPOT1. Telomere fusions, fragile telomeres and missing telomeres are indicated by red, pink and green arrows respectively. Scale bar is 5 μm. ( b - d ), Quantification of telomere fusions, fragile, and missing telomeres from the metaphase spreads of ( a ). Bars indicate the per cent of metaphase events. Error bars are indicating s.d. An average of 500 chromosomes were counted in each experiment.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Telomeric FISH metaphase spreads of cells expressing WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1 proteins after 50 population doublings (Red, TelC-Tamra; blue, DAPI). Endogenous POT1 levels were reduced with shPOT1. Telomere fusions, fragile telomeres and missing telomeres are indicated by red, pink and green arrows respectively. Scale bar is 5 μm. ( b - d ), Quantification of telomere fusions, fragile, and missing telomeres from the metaphase spreads of ( a ). Bars indicate the per cent of metaphase events. Error bars are indicating s.d. An average of 500 chromosomes were counted in each experiment.

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: Expressing, Mutagenesis

    ( a ) Primary structure of POT1 and TPP1 showing domains and their functional properties. POT1C disease mutations (L343F, P446Q, P475L, R477T, A532P, C591W and Q623H) discussed in this manuscript are also indicated. ( b ) SDS–page gel of the purified POT1C and TPP1(PBD) proteins used in structural and biochemical studies. ( c ) Stereo image of a portion (TPP1 bound to the OB-fold of POT1) of the simulated annealing omit map at 1 sigma contour level. ( d ) X-ray Crystal structure of the human POT1C—TPP1(PBD) complex; The OB-fold and HJR of POT1C are shown in blue and red colours respectively; TPP1(PBD) is shown in green colour. The Zn 2+ ion coordinated by 4 cysteins (C382, C385, C503 and C506—stick) is shown as a cyan sphere. ( e ) Overlay of the POT1C and the Oxytricha nova telomere end binding protein alpha subunit (OnTEBPα—beige colour, PDB ID: 1OTC (ref. )) OB folds. ( f ) Overlay of the POT1C HJR (red colour) with its closest structural homologue Archaeoglobus fulgidus HJR (AfHJR—cyan colour; PDB ID: 2WIW).

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Primary structure of POT1 and TPP1 showing domains and their functional properties. POT1C disease mutations (L343F, P446Q, P475L, R477T, A532P, C591W and Q623H) discussed in this manuscript are also indicated. ( b ) SDS–page gel of the purified POT1C and TPP1(PBD) proteins used in structural and biochemical studies. ( c ) Stereo image of a portion (TPP1 bound to the OB-fold of POT1) of the simulated annealing omit map at 1 sigma contour level. ( d ) X-ray Crystal structure of the human POT1C—TPP1(PBD) complex; The OB-fold and HJR of POT1C are shown in blue and red colours respectively; TPP1(PBD) is shown in green colour. The Zn 2+ ion coordinated by 4 cysteins (C382, C385, C503 and C506—stick) is shown as a cyan sphere. ( e ) Overlay of the POT1C and the Oxytricha nova telomere end binding protein alpha subunit (OnTEBPα—beige colour, PDB ID: 1OTC (ref. )) OB folds. ( f ) Overlay of the POT1C HJR (red colour) with its closest structural homologue Archaeoglobus fulgidus HJR (AfHJR—cyan colour; PDB ID: 2WIW).

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: Functional Assay, SDS Page, Purification, Binding Assay

    ( a ) SDS–PAGE gel of super-telomerase extract (STE) and E. coli purified full-length POT1 (flPOT1) and TPP1(87) proteins used in the direct assay of ( c ). The red arrow indicates where TERT is expected to run (∼130 kDa). The assay in c was carried out in the presence of 150 nM of purified POT1–TPP1 complex. ( b ) Western blot of HEK293T lysates used in the direct assay of panel ( d ). The gel shows the levels of transiently expressed POT1 and TPP1 are much higher than those of TERT, confirming that the direct assays were carried out at saturating levels of POT1 and TPP1. ( c ) Telomerase direct activity assay using 2 μg of STE; 150 nM purified WT or mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1; 150 nM WT TPP1(87); and 20 nM of primer A5 (TTAGGGTTAGCGTTAGGG). ( d ) Telomerase direct activity assay using 5 μg of STE co-transfected with WT or mutant (L343F, P466Q, P475L, R477T, A532P, C591W and Q623H) flPOT1 and WT full-length TPP1 (flTPP1). The STE was supplemented with 20 nM of A5 primer. The number of telomeric repeats added to the primer are indicated on the right of the gels ( c and d , e and f ) Quantification of telomerase processivity of panels ( c ) and ( d ) respectively. The values are the average of four independent experiments; error bars indicate s.d.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) SDS–PAGE gel of super-telomerase extract (STE) and E. coli purified full-length POT1 (flPOT1) and TPP1(87) proteins used in the direct assay of ( c ). The red arrow indicates where TERT is expected to run (∼130 kDa). The assay in c was carried out in the presence of 150 nM of purified POT1–TPP1 complex. ( b ) Western blot of HEK293T lysates used in the direct assay of panel ( d ). The gel shows the levels of transiently expressed POT1 and TPP1 are much higher than those of TERT, confirming that the direct assays were carried out at saturating levels of POT1 and TPP1. ( c ) Telomerase direct activity assay using 2 μg of STE; 150 nM purified WT or mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1; 150 nM WT TPP1(87); and 20 nM of primer A5 (TTAGGGTTAGCGTTAGGG). ( d ) Telomerase direct activity assay using 5 μg of STE co-transfected with WT or mutant (L343F, P466Q, P475L, R477T, A532P, C591W and Q623H) flPOT1 and WT full-length TPP1 (flTPP1). The STE was supplemented with 20 nM of A5 primer. The number of telomeric repeats added to the primer are indicated on the right of the gels ( c and d , e and f ) Quantification of telomerase processivity of panels ( c ) and ( d ) respectively. The values are the average of four independent experiments; error bars indicate s.d.

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: SDS Page, Purification, Western Blot, Activity Assay, Mutagenesis, Transfection

    ( a ) FP assays of POT1C and the POT1C–TPP1(PBD) complex with a single-stranded DNA probe consisting of 3 telomeric repeats (18mer). ( b ) FP assays of the WT and mutant (those that partially disrupt the POT1–TPP1 complex P446Q, C591W and Q623H) flPOT1 with the 18mer DNA probe. ( c ) FP assays of the WT and mutant flPOT1−TPP1(87) complex with the 18mer. ( d ) Bar graph showing the differences in Kd (nM) between the WT and mutant flPOT1 and flPOT1–TPP1(87) complex. The values are the average of three independent measurements and a two-tailed Student's t -test was performed with respect to WT POT1–TPP1(PBD) complex: * P <0.05, ** P <0.01.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) FP assays of POT1C and the POT1C–TPP1(PBD) complex with a single-stranded DNA probe consisting of 3 telomeric repeats (18mer). ( b ) FP assays of the WT and mutant (those that partially disrupt the POT1–TPP1 complex P446Q, C591W and Q623H) flPOT1 with the 18mer DNA probe. ( c ) FP assays of the WT and mutant flPOT1−TPP1(87) complex with the 18mer. ( d ) Bar graph showing the differences in Kd (nM) between the WT and mutant flPOT1 and flPOT1–TPP1(87) complex. The values are the average of three independent measurements and a two-tailed Student's t -test was performed with respect to WT POT1–TPP1(PBD) complex: * P <0.05, ** P <0.01.

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: Mutagenesis, Two Tailed Test

    ( a ) Western blot showing the levels of YFP tagged, WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) full length POT1. We used GFP (αGFP) or POT1 (αPOT1) to detect the levels of YFP-POT1 in each cell line. The band at 71 kDa and below the YFP-aPOT1 is a non specific protein. GAPDH was used as a loading control. ( b ) Maximum projection images of co-localization of YFP-POT1 (green) and Cherry-TRF2 (red) proteins are shown. Merged images include DAPI. Scale bar, 5 μm. The data clearly shows co-localization of WT and mutant flPOT1 proteins to telomeres.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Western blot showing the levels of YFP tagged, WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) full length POT1. We used GFP (αGFP) or POT1 (αPOT1) to detect the levels of YFP-POT1 in each cell line. The band at 71 kDa and below the YFP-aPOT1 is a non specific protein. GAPDH was used as a loading control. ( b ) Maximum projection images of co-localization of YFP-POT1 (green) and Cherry-TRF2 (red) proteins are shown. Merged images include DAPI. Scale bar, 5 μm. The data clearly shows co-localization of WT and mutant flPOT1 proteins to telomeres.

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: Western Blot, Mutagenesis, Control

    ( a ) Quantitative RT-PCR showing knock down of endogenous POT1 mRNA, normalized to GAPDH transcript levels, after lentiviral infection of HEK293T cells with shPOT1 and WT Flag-POT1; selection was carried out with puromycin and blasticidin;±s.d. ( n =3). ( b ) Western blot showing WT and mutant POT1 protein expression levels in HEK293T cells expressing shPOT1 and Flag-POT1. Cells infected with the empty pLU and pLKO.1 lentiviral vectors are used as controls. ( c , d , e ) Southern blot of HEK293T cells expressing shPOT1 and WT or mutant flPOT1. DNA from 5, 50 and 120 populations doublings (PD) is shown. DNA length standards are indicated along the left and right of the gels. The white dashed line indicates the average telomere length of HEK293T cells transfected with the vector alone and no shPOT1 after 5, 50 and 120 PD. The vector (- shPOT1), vector (+shPOT1) and WT POT1 (+shPOT1) controls are indicated with a green and yellow dot respectively. The POT1 mutants (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) are indicated with red dots. ( f ) Quantification of the mean telomere length (kb) from panels ( c , d and e ). The same colour scheme as in panels c , d and e is used. Black bars indicate the range of telomere restriction fragments (TRF).

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Quantitative RT-PCR showing knock down of endogenous POT1 mRNA, normalized to GAPDH transcript levels, after lentiviral infection of HEK293T cells with shPOT1 and WT Flag-POT1; selection was carried out with puromycin and blasticidin;±s.d. ( n =3). ( b ) Western blot showing WT and mutant POT1 protein expression levels in HEK293T cells expressing shPOT1 and Flag-POT1. Cells infected with the empty pLU and pLKO.1 lentiviral vectors are used as controls. ( c , d , e ) Southern blot of HEK293T cells expressing shPOT1 and WT or mutant flPOT1. DNA from 5, 50 and 120 populations doublings (PD) is shown. DNA length standards are indicated along the left and right of the gels. The white dashed line indicates the average telomere length of HEK293T cells transfected with the vector alone and no shPOT1 after 5, 50 and 120 PD. The vector (- shPOT1), vector (+shPOT1) and WT POT1 (+shPOT1) controls are indicated with a green and yellow dot respectively. The POT1 mutants (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) are indicated with red dots. ( f ) Quantification of the mean telomere length (kb) from panels ( c , d and e ). The same colour scheme as in panels c , d and e is used. Black bars indicate the range of telomere restriction fragments (TRF).

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: Quantitative RT-PCR, Knockdown, Infection, Selection, Western Blot, Mutagenesis, Expressing, Southern Blot, Transfection, Plasmid Preparation

    ( a ) Telomeric FISH metaphase spreads of cells expressing WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1 proteins after 50 population doublings (Red, TelC-Tamra; blue, DAPI). Endogenous POT1 levels were reduced with shPOT1. Telomere fusions, fragile telomeres and missing telomeres are indicated by red, pink and green arrows respectively. Scale bar is 5 μm. ( b - d ), Quantification of telomere fusions, fragile, and missing telomeres from the metaphase spreads of ( a ). Bars indicate the per cent of metaphase events. Error bars are indicating s.d. An average of 500 chromosomes were counted in each experiment.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Telomeric FISH metaphase spreads of cells expressing WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1 proteins after 50 population doublings (Red, TelC-Tamra; blue, DAPI). Endogenous POT1 levels were reduced with shPOT1. Telomere fusions, fragile telomeres and missing telomeres are indicated by red, pink and green arrows respectively. Scale bar is 5 μm. ( b - d ), Quantification of telomere fusions, fragile, and missing telomeres from the metaphase spreads of ( a ). Bars indicate the per cent of metaphase events. Error bars are indicating s.d. An average of 500 chromosomes were counted in each experiment.

    Article Snippet: For the western blot analysis of HEK293T cells co-transfected with hTERT, hTER, POT1 and TPP1, standard immunoblot protocols were used with the following antibody dilutions: anti-human TERT (abx120550, Abbexa, 1:1,000, dilution), anti-human POT1 antibody (ab21283, Abcam, 1:1,000 dilution), anti-human ACD (SAB2100024, Sigma, 1:1,000 dilution), anti-Actin antibody conjugated to HRP (A3854, Sigma, 1:1,000 dilution), and secondary HRP-conjugated anti-sheep IgG (sc-2924, Santa Cruz, 1:1,000) and anti-rabbit IgG (A0545, Sigma, 1:1,000 dilution) were used to detect the human TERT and human POT1 and TPP1 antibody, respectively.

    Techniques: Expressing, Mutagenesis

    ( a ) Primary structure of POT1 and TPP1 showing domains and their functional properties. POT1C disease mutations (L343F, P446Q, P475L, R477T, A532P, C591W and Q623H) discussed in this manuscript are also indicated. ( b ) SDS–page gel of the purified POT1C and TPP1(PBD) proteins used in structural and biochemical studies. ( c ) Stereo image of a portion (TPP1 bound to the OB-fold of POT1) of the simulated annealing omit map at 1 sigma contour level. ( d ) X-ray Crystal structure of the human POT1C—TPP1(PBD) complex; The OB-fold and HJR of POT1C are shown in blue and red colours respectively; TPP1(PBD) is shown in green colour. The Zn 2+ ion coordinated by 4 cysteins (C382, C385, C503 and C506—stick) is shown as a cyan sphere. ( e ) Overlay of the POT1C and the Oxytricha nova telomere end binding protein alpha subunit (OnTEBPα—beige colour, PDB ID: 1OTC (ref. )) OB folds. ( f ) Overlay of the POT1C HJR (red colour) with its closest structural homologue Archaeoglobus fulgidus HJR (AfHJR—cyan colour; PDB ID: 2WIW).

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Primary structure of POT1 and TPP1 showing domains and their functional properties. POT1C disease mutations (L343F, P446Q, P475L, R477T, A532P, C591W and Q623H) discussed in this manuscript are also indicated. ( b ) SDS–page gel of the purified POT1C and TPP1(PBD) proteins used in structural and biochemical studies. ( c ) Stereo image of a portion (TPP1 bound to the OB-fold of POT1) of the simulated annealing omit map at 1 sigma contour level. ( d ) X-ray Crystal structure of the human POT1C—TPP1(PBD) complex; The OB-fold and HJR of POT1C are shown in blue and red colours respectively; TPP1(PBD) is shown in green colour. The Zn 2+ ion coordinated by 4 cysteins (C382, C385, C503 and C506—stick) is shown as a cyan sphere. ( e ) Overlay of the POT1C and the Oxytricha nova telomere end binding protein alpha subunit (OnTEBPα—beige colour, PDB ID: 1OTC (ref. )) OB folds. ( f ) Overlay of the POT1C HJR (red colour) with its closest structural homologue Archaeoglobus fulgidus HJR (AfHJR—cyan colour; PDB ID: 2WIW).

    Article Snippet: For western blot analysis of HEK293T cells stably expressing shPOT1 and WT and mutant POT1 proteins, standard immunoblot protocols were used with the following antibody dilutions: anti-human POT1 antibody (P0096, Sigma, 1:1,000 dilution), anti-GAPDH antibody conjugated to HRP (2118S; Cell Signaling Technology, Danvers, MA; 1:5,000 dilution), and secondary HRP-conjugated anti-rabbit IgG antibody (A0545, Sigma, 1:1,000 dilution) was used to detect the human POT1 antibody.

    Techniques: Functional Assay, SDS Page, Purification, Binding Assay

    ( a ) SDS–PAGE gel of super-telomerase extract (STE) and E. coli purified full-length POT1 (flPOT1) and TPP1(87) proteins used in the direct assay of ( c ). The red arrow indicates where TERT is expected to run (∼130 kDa). The assay in c was carried out in the presence of 150 nM of purified POT1–TPP1 complex. ( b ) Western blot of HEK293T lysates used in the direct assay of panel ( d ). The gel shows the levels of transiently expressed POT1 and TPP1 are much higher than those of TERT, confirming that the direct assays were carried out at saturating levels of POT1 and TPP1. ( c ) Telomerase direct activity assay using 2 μg of STE; 150 nM purified WT or mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1; 150 nM WT TPP1(87); and 20 nM of primer A5 (TTAGGGTTAGCGTTAGGG). ( d ) Telomerase direct activity assay using 5 μg of STE co-transfected with WT or mutant (L343F, P466Q, P475L, R477T, A532P, C591W and Q623H) flPOT1 and WT full-length TPP1 (flTPP1). The STE was supplemented with 20 nM of A5 primer. The number of telomeric repeats added to the primer are indicated on the right of the gels ( c and d , e and f ) Quantification of telomerase processivity of panels ( c ) and ( d ) respectively. The values are the average of four independent experiments; error bars indicate s.d.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) SDS–PAGE gel of super-telomerase extract (STE) and E. coli purified full-length POT1 (flPOT1) and TPP1(87) proteins used in the direct assay of ( c ). The red arrow indicates where TERT is expected to run (∼130 kDa). The assay in c was carried out in the presence of 150 nM of purified POT1–TPP1 complex. ( b ) Western blot of HEK293T lysates used in the direct assay of panel ( d ). The gel shows the levels of transiently expressed POT1 and TPP1 are much higher than those of TERT, confirming that the direct assays were carried out at saturating levels of POT1 and TPP1. ( c ) Telomerase direct activity assay using 2 μg of STE; 150 nM purified WT or mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1; 150 nM WT TPP1(87); and 20 nM of primer A5 (TTAGGGTTAGCGTTAGGG). ( d ) Telomerase direct activity assay using 5 μg of STE co-transfected with WT or mutant (L343F, P466Q, P475L, R477T, A532P, C591W and Q623H) flPOT1 and WT full-length TPP1 (flTPP1). The STE was supplemented with 20 nM of A5 primer. The number of telomeric repeats added to the primer are indicated on the right of the gels ( c and d , e and f ) Quantification of telomerase processivity of panels ( c ) and ( d ) respectively. The values are the average of four independent experiments; error bars indicate s.d.

    Article Snippet: For western blot analysis of HEK293T cells stably expressing shPOT1 and WT and mutant POT1 proteins, standard immunoblot protocols were used with the following antibody dilutions: anti-human POT1 antibody (P0096, Sigma, 1:1,000 dilution), anti-GAPDH antibody conjugated to HRP (2118S; Cell Signaling Technology, Danvers, MA; 1:5,000 dilution), and secondary HRP-conjugated anti-rabbit IgG antibody (A0545, Sigma, 1:1,000 dilution) was used to detect the human POT1 antibody.

    Techniques: SDS Page, Purification, Western Blot, Activity Assay, Mutagenesis, Transfection

    ( a ) FP assays of POT1C and the POT1C–TPP1(PBD) complex with a single-stranded DNA probe consisting of 3 telomeric repeats (18mer). ( b ) FP assays of the WT and mutant (those that partially disrupt the POT1–TPP1 complex P446Q, C591W and Q623H) flPOT1 with the 18mer DNA probe. ( c ) FP assays of the WT and mutant flPOT1−TPP1(87) complex with the 18mer. ( d ) Bar graph showing the differences in Kd (nM) between the WT and mutant flPOT1 and flPOT1–TPP1(87) complex. The values are the average of three independent measurements and a two-tailed Student's t -test was performed with respect to WT POT1–TPP1(PBD) complex: * P <0.05, ** P <0.01.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) FP assays of POT1C and the POT1C–TPP1(PBD) complex with a single-stranded DNA probe consisting of 3 telomeric repeats (18mer). ( b ) FP assays of the WT and mutant (those that partially disrupt the POT1–TPP1 complex P446Q, C591W and Q623H) flPOT1 with the 18mer DNA probe. ( c ) FP assays of the WT and mutant flPOT1−TPP1(87) complex with the 18mer. ( d ) Bar graph showing the differences in Kd (nM) between the WT and mutant flPOT1 and flPOT1–TPP1(87) complex. The values are the average of three independent measurements and a two-tailed Student's t -test was performed with respect to WT POT1–TPP1(PBD) complex: * P <0.05, ** P <0.01.

    Article Snippet: For western blot analysis of HEK293T cells stably expressing shPOT1 and WT and mutant POT1 proteins, standard immunoblot protocols were used with the following antibody dilutions: anti-human POT1 antibody (P0096, Sigma, 1:1,000 dilution), anti-GAPDH antibody conjugated to HRP (2118S; Cell Signaling Technology, Danvers, MA; 1:5,000 dilution), and secondary HRP-conjugated anti-rabbit IgG antibody (A0545, Sigma, 1:1,000 dilution) was used to detect the human POT1 antibody.

    Techniques: Mutagenesis, Two Tailed Test

    ( a ) Western blot showing the levels of YFP tagged, WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) full length POT1. We used GFP (αGFP) or POT1 (αPOT1) to detect the levels of YFP-POT1 in each cell line. The band at 71 kDa and below the YFP-aPOT1 is a non specific protein. GAPDH was used as a loading control. ( b ) Maximum projection images of co-localization of YFP-POT1 (green) and Cherry-TRF2 (red) proteins are shown. Merged images include DAPI. Scale bar, 5 μm. The data clearly shows co-localization of WT and mutant flPOT1 proteins to telomeres.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Western blot showing the levels of YFP tagged, WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) full length POT1. We used GFP (αGFP) or POT1 (αPOT1) to detect the levels of YFP-POT1 in each cell line. The band at 71 kDa and below the YFP-aPOT1 is a non specific protein. GAPDH was used as a loading control. ( b ) Maximum projection images of co-localization of YFP-POT1 (green) and Cherry-TRF2 (red) proteins are shown. Merged images include DAPI. Scale bar, 5 μm. The data clearly shows co-localization of WT and mutant flPOT1 proteins to telomeres.

    Article Snippet: For western blot analysis of HEK293T cells stably expressing shPOT1 and WT and mutant POT1 proteins, standard immunoblot protocols were used with the following antibody dilutions: anti-human POT1 antibody (P0096, Sigma, 1:1,000 dilution), anti-GAPDH antibody conjugated to HRP (2118S; Cell Signaling Technology, Danvers, MA; 1:5,000 dilution), and secondary HRP-conjugated anti-rabbit IgG antibody (A0545, Sigma, 1:1,000 dilution) was used to detect the human POT1 antibody.

    Techniques: Western Blot, Mutagenesis

    ( a ) Quantitative RT-PCR showing knock down of endogenous POT1 mRNA, normalized to GAPDH transcript levels, after lentiviral infection of HEK293T cells with shPOT1 and WT Flag-POT1; selection was carried out with puromycin and blasticidin;±s.d. ( n =3). ( b ) Western blot showing WT and mutant POT1 protein expression levels in HEK293T cells expressing shPOT1 and Flag-POT1. Cells infected with the empty pLU and pLKO.1 lentiviral vectors are used as controls. ( c , d , e ) Southern blot of HEK293T cells expressing shPOT1 and WT or mutant flPOT1. DNA from 5, 50 and 120 populations doublings (PD) is shown. DNA length standards are indicated along the left and right of the gels. The white dashed line indicates the average telomere length of HEK293T cells transfected with the vector alone and no shPOT1 after 5, 50 and 120 PD. The vector (- shPOT1), vector (+shPOT1) and WT POT1 (+shPOT1) controls are indicated with a green and yellow dot respectively. The POT1 mutants (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) are indicated with red dots. ( f ) Quantification of the mean telomere length (kb) from panels ( c , d and e ). The same colour scheme as in panels c , d and e is used. Black bars indicate the range of telomere restriction fragments (TRF).

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Quantitative RT-PCR showing knock down of endogenous POT1 mRNA, normalized to GAPDH transcript levels, after lentiviral infection of HEK293T cells with shPOT1 and WT Flag-POT1; selection was carried out with puromycin and blasticidin;±s.d. ( n =3). ( b ) Western blot showing WT and mutant POT1 protein expression levels in HEK293T cells expressing shPOT1 and Flag-POT1. Cells infected with the empty pLU and pLKO.1 lentiviral vectors are used as controls. ( c , d , e ) Southern blot of HEK293T cells expressing shPOT1 and WT or mutant flPOT1. DNA from 5, 50 and 120 populations doublings (PD) is shown. DNA length standards are indicated along the left and right of the gels. The white dashed line indicates the average telomere length of HEK293T cells transfected with the vector alone and no shPOT1 after 5, 50 and 120 PD. The vector (- shPOT1), vector (+shPOT1) and WT POT1 (+shPOT1) controls are indicated with a green and yellow dot respectively. The POT1 mutants (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) are indicated with red dots. ( f ) Quantification of the mean telomere length (kb) from panels ( c , d and e ). The same colour scheme as in panels c , d and e is used. Black bars indicate the range of telomere restriction fragments (TRF).

    Article Snippet: For western blot analysis of HEK293T cells stably expressing shPOT1 and WT and mutant POT1 proteins, standard immunoblot protocols were used with the following antibody dilutions: anti-human POT1 antibody (P0096, Sigma, 1:1,000 dilution), anti-GAPDH antibody conjugated to HRP (2118S; Cell Signaling Technology, Danvers, MA; 1:5,000 dilution), and secondary HRP-conjugated anti-rabbit IgG antibody (A0545, Sigma, 1:1,000 dilution) was used to detect the human POT1 antibody.

    Techniques: Quantitative RT-PCR, Infection, Selection, Western Blot, Mutagenesis, Expressing, Southern Blot, Transfection, Plasmid Preparation

    ( a ) Telomeric FISH metaphase spreads of cells expressing WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1 proteins after 50 population doublings (Red, TelC-Tamra; blue, DAPI). Endogenous POT1 levels were reduced with shPOT1. Telomere fusions, fragile telomeres and missing telomeres are indicated by red, pink and green arrows respectively. Scale bar is 5 μm. ( b - d ), Quantification of telomere fusions, fragile, and missing telomeres from the metaphase spreads of ( a ). Bars indicate the per cent of metaphase events. Error bars are indicating s.d. An average of 500 chromosomes were counted in each experiment.

    Journal: Nature Communications

    Article Title: Structural and functional analysis of the human POT1-TPP1 telomeric complex

    doi: 10.1038/ncomms14928

    Figure Lengend Snippet: ( a ) Telomeric FISH metaphase spreads of cells expressing WT and mutant (L343F, P466Q, P475L, R477T, A532P, I535F, C591W and Q623H) flPOT1 proteins after 50 population doublings (Red, TelC-Tamra; blue, DAPI). Endogenous POT1 levels were reduced with shPOT1. Telomere fusions, fragile telomeres and missing telomeres are indicated by red, pink and green arrows respectively. Scale bar is 5 μm. ( b - d ), Quantification of telomere fusions, fragile, and missing telomeres from the metaphase spreads of ( a ). Bars indicate the per cent of metaphase events. Error bars are indicating s.d. An average of 500 chromosomes were counted in each experiment.

    Article Snippet: For western blot analysis of HEK293T cells stably expressing shPOT1 and WT and mutant POT1 proteins, standard immunoblot protocols were used with the following antibody dilutions: anti-human POT1 antibody (P0096, Sigma, 1:1,000 dilution), anti-GAPDH antibody conjugated to HRP (2118S; Cell Signaling Technology, Danvers, MA; 1:5,000 dilution), and secondary HRP-conjugated anti-rabbit IgG antibody (A0545, Sigma, 1:1,000 dilution) was used to detect the human POT1 antibody.

    Techniques: Expressing, Mutagenesis